New combo therapy aims to shrink lung tumors without chemo or surgery
NCT ID NCT07224152
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called NBTXR3 given with radiation therapy for people with locally-advanced non-small cell lung cancer who cannot have chemotherapy or surgery. The goal is to see if the combination is safe and helps control the cancer. About 40 adults with stage I to III lung cancer will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a PET scan reveal hidden heart harm from lung cancer treatment?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can a new drug shrink Hard-to-Treat tumors?
- Could an asthma drug help fight lung cancer? early trial investigates
- New combo therapy aims to boost lung cancer survival
- Radiation 'Priming' could make lung cancer treatment more effective